B. Starcher et al., INHIBITION OF NEUTROPHIL ELASTASE SUPPRESSES THE DEVELOPMENT OF SKIN TUMORS IN HAIRLESS MICE, Journal of investigative dermatology, 107(2), 1996, pp. 159-163
In this study we investigated whether a reduction in neutrophil elasta
se activity in mice would alter the development of ultraviolet B or ch
emically induced skin tumors. A mutant strain of neutrophil elastase-d
eficient mice was developed by crossing beige mice with SKH 1 hairless
mice. Ultraviolet irradiation three times per week for 20 wk develope
d an average of 10 tumors per normal mouse, whereas elastase-deficient
hairless mice receiving the same treatment developed only 0.4 tumors
per mouse. Benzopyrene administered topically for 20 wk resulted in an
average of seven tumors per control mouse, while similar treatment to
elastase-deficient hairless mice reduced the tumor count to 0.2 per m
ouse. Two small molecular weight elastase inhibitors, which were shown
to inhibit mouse neutrophil elastase, were administered subcutaneousl
y to normal SKH-1 mice during 16 wk of ultraviolet B exposure. Both in
hibitors significantly reduced the incidence of ultraviolet B-induced
tumors. When control and elastase-deficient mice were immunized with 2
,4,6-trinitrochlorobenzene and oxazolone, both molecules elicited a si
gnificant contact hypersensitivity response. Ultraviolet B irradiation
prior to immunization at a nonirradiated site completely suppressed t
he induction of contact hypersensitivity in both the normal and the de
ficient mice, suggesting that prevention of systemic immunosuppression
was not the reason for the resistance to skin tumors observed in the
elastase-deficient mice. The results suggest that neutrophil elastase
can be an important factor in squamous cell tumor development.